F-D-A APPROVES NEW ALZHEIMER'S DRUG - KISUNLA
The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline ...
FiercePharma4d
The end of the beginning: Lilly execs eye top spot in burgeoning Alzheimer's market after Kisunla's FDA approval
Following this month's FDA approval of Eli Lilly’s amyloid-busting antibody Kisunla (donanemab), the Alzheimer’s disease ...
FierceBiotech1h
Novo Holdings, J&J-backed Asceneuron raises $100M to take Alzheimer's asset into phase 2
With the first wave of Alzheimer’s disease drugs reaching the market, investors continue to seek out the next big advance in ...
Why new treatments for Alzheimer's cost tens of thousands of dollars a year
The Food and Drug Administration approved a new Eli Lilly drug this month that treats Alzheimer's disease. Kisunla is an IV ...
Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
The new drug, Kisunla, has the potential to be a blockbuster for the company and generate billions in revenue. But despite ...
Bill McEwen5d
FDA Approves Second Drug to Modestly Slow Alzheimer's Disease
Learn about the benefits of Kisunla, the newly approved Alzheimer's drug that can modestly slow disease progression in the ...
FierceBiotech16h
Lantheus acquires Alzheimer’s PET diagnostic developer Meilleur Technologies
Lantheus is expanding its holdings of PET imaging agents for Alzheimer’s disease, with the acquisition of Meilleur ...
Asceneuron raises another $100M for Alzheimer’s drug development
The Merck KGaA spinout has a tau-regulating medicine it claims could be an “ideal therapy” for Alzheimer’s. The pitch has intrigued both healthcare investors and pharma venture arms.
clinicaladvisor.com6d
Kisunla Approved for Early Symptomatic Alzheimer Disease
The approval was based on data from the double-blind, placebo-controlled TRAILBLAZER-ALZ 2 study. The Food and Drug Administration (FDA) has approved Kisunla ™ (donanemab-azbt) for the treatment of ...
Is Eli Lilly Stock a No-Brainer Buy After Its FDA Alzheimer's Disease Drug Win?
Lilly argues that Kisunla could be less costly to payers than rivals. It's the only FDA-approved Alzheimer's disease drug ...
Flow Space on MSN3d
Everything You Need to Know About Kisunla, The New FDA-Approved Alzheimer's Drug
The latest drug is showing promising results for adults with early Alzheimer's symptoms, mild cognitive impairment (MCI), and ...